Loading clinical trials...
Loading clinical trials...
Randomised, Double-blind, Dose-finding Phase II Study to Assess the Efficacy of APD403 in the Prevention of Nausea and Vomiting Caused by Cisplatin- or Anthracycline/Cyclophosphamide (AC)-Based Chemotherapy
Conditions
Interventions
Ondansetron
Placebo
+4 more
Locations
1
Denmark
Odense University Hospital
Odense, Denmark
Start Date
October 1, 2013
Primary Completion Date
February 1, 2015
Completion Date
February 1, 2015
Last Updated
November 25, 2020
NCT05244577
NCT04472143
NCT00952341
NCT01111851
Lead Sponsor
Acacia Pharma Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions